Literature DB >> 24042467

Diabetes: Assessing renal risk in patients with type 2 diabetes.

Merlin C Thomas1, Per-Henrik Groop.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24042467     DOI： 10.1038/nrneph.2013.181

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease.

Authors:  Hiddo J Lambers Heerspink; Toshiharu Ninomiya; Vlado Perkovic; Mark Woodward; Sophia Zoungas; Alan Cass; Mark Cooper; Diederick E Grobbee; Giuseppe Mancia; Carl Eric Mogensen; Bruce Neal; John Chalmers
Journal:  Eur Heart J       Date:  2010-05-25       Impact factor: 29.983

2.  General medical care among patients with chronic kidney disease: opportunities for improving outcomes.

Authors:  Annamaria T Kausz; Haifeng Guo; Brian J G Pereira; Allan J Collins; David T Gilbertson
Journal:  J Am Soc Nephrol       Date:  2005-08-03       Impact factor: 10.121

3.  Screening for chronic kidney disease in patients with diabetes: are we missing the point?

Authors:  Merlin C Thomas; GianCarlo Viberti; Per-Henrik Groop
Journal:  Nat Clin Pract Nephrol       Date:  2007-11-27

4.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

Authors:  R J Stevens; V Kothari; A I Adler; I M Stratton
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

5.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

Authors:  Andrew S Levey; Paul E de Jong; Josef Coresh; Meguid El Nahas; Brad C Astor; Kunihiro Matsushita; Ron T Gansevoort; Bertram L Kasiske; Kai-Uwe Eckardt
Journal:  Kidney Int       Date:  2010-12-08       Impact factor: 10.612

6.  Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

Authors:  Carol Forsblom; Valma Harjutsalo; Lena M Thorn; Johan Wadén; Nina Tolonen; Markku Saraheimo; Daniel Gordin; John L Moran; Merlin C Thomas; Per-Henrik Groop
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

7.  Prediction of kidney-related outcomes in patients with type 2 diabetes.

Authors:  Meg J Jardine; Jun Hata; Mark Woodward; Vlado Perkovic; Toshiharu Ninomiya; Hisatomi Arima; Sophia Zoungas; Alan Cass; Anushka Patel; Michel Marre; Giuseppe Mancia; Carl E Mogensen; Neil Poulter; John Chalmers
Journal:  Am J Kidney Dis       Date:  2012-06-12       Impact factor: 8.860

8.  Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  P L Drury; R Ting; D Zannino; C Ehnholm; J Flack; M Whiting; R Fassett; J-C Ansquer; P Dixon; T M E Davis; C Pardy; P Colman; A Keech
Journal:  Diabetologia       Date:  2010-07-30       Impact factor: 10.122

9.  Derivation and validation of a renal risk score for people with type 2 diabetes.

Authors:  C Raina Elley; Tom Robinson; Simon A Moyes; Tim Kenealy; John Collins; Elizabeth Robinson; Brandon Orr-Walker; Paul L Drury
Journal:  Diabetes Care       Date:  2013-06-25       Impact factor: 19.112

10.  Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.

Authors:  Simon D S Fraser; Paul J Roderick; Natasha J McIntyre; Scott Harris; Christopher W McIntyre; Richard J Fluck; Maarten W Taal
Journal:  BMC Fam Pract       Date:  2013-06-24       Impact factor: 2.497
  10 in total
  2 in total

1.  Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs.

Authors:  Guntram Schernthaner; Avraham Karasik; Agnė Abraitienė; Alexander S Ametov; Zsolt Gaàl; Janusz Gumprecht; Andrej Janež; Susanne Kaser; Katarina Lalić; Boris N Mankovsky; Evgeny Moshkovich; Marju Past; Martin Prázný; Gabriela Radulian; Lea Smirčić Duvnjak; Ivan Tkáč; Kārlis Trušinskis
Journal:  Cardiovasc Diabetol       Date:  2019-08-31       Impact factor: 9.951

Review 2.  Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria.

Authors:  P Iyngkaran; M Thomas
Journal:  Clin Med Insights Cardiol       Date:  2015-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.